safety
Articles tagged with “safety”
Ketamine in Pregnancy and Lactation: Safety Considerations and Data Gaps
Comprehensive review of ketamine safety in pregnancy and lactation, examining preclinical developmental toxicity, limited human data, breastfeeding transfer, and risk-benefit framework.
Ketamine Tolerance and Long-Term Use: What Clinicians Need to Know
Clinical review of tolerance development during long-term ketamine therapy, including mechanisms, detection strategies, and evidence-based management approaches.
Managing Nausea and Vomiting During Ketamine Therapy
Clinical guide to preventing and treating ketamine-induced nausea and vomiting, covering antiemetic protocols, risk factors, and non-pharmacological strategies.
Long-Term Safety Considerations for Ketamine Therapy
An evidence-based review of safety concerns associated with repeated or prolonged low-dose ketamine use, including urological toxicity, neurocognitive effects, hepatic complications, and the potential for psychological and physiological dependence.
How Long Do Ketamine Side Effects Last?
Most ketamine side effects resolve within 1 to 2 hours after an infusion ends, with subtle residual effects fading within 4 to 6 hours.
Ketamine and SSRIs: Drug Interaction Deep Dive
A clinician-focused analysis of pharmacological interactions between ketamine and selective serotonin reuptake inhibitors, covering serotonin syndrome risk, clinical evidence on concurrent use, and dosing adjustment considerations.
Ketamine and Bladder Health: Urological Safety at Therapeutic Doses
A clinical review of ketamine-associated urological toxicity, examining the evidence at recreational versus therapeutic dose levels, pathophysiological mechanisms, risk factors, monitoring recommendations, and protective strategies for patients receiving low-dose ketamine treatment.
Ketamine and Liver Function Tests: Monitoring LFTs During Therapy
A clinical guide to liver function test monitoring during low-dose ketamine therapy, including baseline assessment, frequency of testing, interpreting abnormal results, and managing hepatotoxicity risk.
Ketamine and Blood Pressure: What Patients Should Know
A patient-oriented clinical guide to understanding ketamine's effects on blood pressure, including why blood pressure rises during treatment, what levels are expected, who is at increased risk, and how clinicians manage cardiovascular responses.
Ketamine and Benzodiazepines: Clinical Interaction Guide
An evidence-based analysis of the interaction between ketamine and benzodiazepines, examining efficacy attenuation, timing considerations, clinical evidence, and management strategies for prescribers.
Is Ketamine Therapy Addictive?
When administered in a supervised clinical setting at low doses, ketamine therapy carries a low risk of addiction, though the drug does have abuse potential.
Low-Dose Ketamine and Alcohol: Patient Safety Guide
A safety-focused guide on the risks and clinical considerations of alcohol use during ketamine therapy, covering pharmacological interactions, metabolism, timing guidelines, and patient counseling strategies.
Ketamine-Associated Hepatotoxicity: Risk Factors and Liver Function Monitoring
Review of ketamine-associated hepatotoxicity including risk factors, proposed mechanisms, liver function monitoring protocols, and clinical management for repeated therapeutic dosing.
Contraindications and Screening Protocols for Ketamine Therapy
A thorough guide to absolute and relative contraindications for low-dose ketamine, along with recommended screening protocols encompassing medical history, psychiatric evaluation, laboratory assessment, and informed consent procedures.
Ketamine Side Effects: A Complete Clinical Guide
Comprehensive evidence-based review of ketamine side effects including dissociation, nausea, cardiovascular changes, and cognitive effects for clinicians.
Cardiovascular Effects of Low-Dose Ketamine: Hemodynamic Monitoring Guidelines
Evidence-based hemodynamic monitoring guidelines for low-dose ketamine, covering sympathomimetic cardiovascular effects, blood pressure management, and cardiac risk stratification.
Cognitive Effects of Repeated Low-Dose Ketamine: Neuropsychological Assessment
Review of cognitive effects of repeated low-dose ketamine treatment, covering acute and chronic impacts on memory, executive function, and neuropsychological assessment strategies.
Can You Drive After Ketamine Treatment?
You should not drive for at least 24 hours after a ketamine infusion due to temporary cognitive and perceptual effects.
Abuse Potential of Therapeutic Ketamine: Risk Stratification and Monitoring
Assessment of abuse potential for therapeutic ketamine, examining risk stratification approaches, monitoring strategies, and safeguards for clinical prescribing programs.
Safety and Side Effects
Important information about the safety profile of low-dose ketamine therapy, including common side effects, serious risks, driving restrictions, and long-term considerations.
Telemedicine Monitoring Protocols for At-Home Ketamine Therapy
Evidence-based guidance on remote monitoring protocols for at-home ketamine administration, covering vital sign monitoring, telehealth check-ins, safety frameworks, and technology requirements.
Clinically Significant Drug Interactions with Low-Dose Ketamine
A comprehensive review of clinically significant drug interactions with therapeutic ketamine, covering CNS depressants, serotonergic agents, CYP enzyme inhibitors, and cardiovascular medications.
Geriatric Considerations in Low-Dose Ketamine Therapy
Clinical guidance on low-dose ketamine use in elderly patients, addressing age-related pharmacokinetic changes, cardiovascular risk stratification, cognitive monitoring, and dose modifications.
Ready to learn more?
Explore our comprehensive guides and tools to help you navigate your ketamine therapy journey.